Anzeige
Erschienen in:
06.08.2021 | COVID-19 | Breast Cancer Disparities (LA Newman, Section Editor)
Breast Cancer Disparities Through the Lens of the COVID-19 Pandemic
Erschienen in: Current Breast Cancer Reports | Ausgabe 3/2021
Einloggen, um Zugang zu erhaltenAbstract
Purpose of Review
The emergency medicine and critical care needs of the COVID-19 pandemic forced a sudden and dramatic disruption of cancer screening and treatment programs in the USA during the winter and spring of 2020. This review commentary addresses the impact of the pandemic on racial/ethnic minorities such as African Americans and Hispanic-Latina Americans, with a focus on factors related to breast cancer.
Recent Findings
African Americans and Hispanic-Latina Americans experienced disproportionately higher morbidity and mortality from COVID-19; many of the same socioeconomic and tumor biology/genetic factors that explain breast cancer disparities are likely to account for COVID-19 outcome disparities.
Summary
The breast cancer clinical and research community should partner with public health experts to ensure participation of diverse patients in COVID-19 treatment trials and vaccine programs and to overcome COVID-19-related breast health management delays that are likely to have been magnified among African Americans and Hispanic-Latina Americans.